메뉴 건너뛰기




Volumn 37, Issue 20, 2016, Pages 1582-1590

The ABC (age, biomarkers, clinical history) stroke risk score: A biomarker-based risk score for predicting stroke in atrial fibrillation

Author keywords

Atrial fibrillation; Biomarkers; Natriuretic peptides; Risk score; Stroke; Troponin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

EID: 84975787058     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw054     Document Type: Article
Times cited : (324)

References (30)
  • 1
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146: 857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 2
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5    Selby, J.V.6    Singer, D.E.7
  • 3
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 4
    • 0032557174 scopus 로고    scopus 로고
    • Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
    • AFI. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 1998;279:1273-1277.
    • (1998) JAMA , vol.279 , pp. 1273-1277
    • AFI1
  • 6
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 7
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137:263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 9
    • 84859424764 scopus 로고    scopus 로고
    • Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: A Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy
    • Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: A Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 2012;125:1605-1616.
    • (2012) Circulation , vol.125 , pp. 1605-1616
    • Hijazi, Z.1    Oldgren, J.2    Andersson, U.3    Connolly, S.J.4    Ezekowitz, M.D.5    Hohnloser, S.H.6    Reilly, P.A.7    Vinereanu, D.8    Siegbahn, A.9    Yusuf, S.10    Wallentin, L.11
  • 17
    • 77955585234 scopus 로고    scopus 로고
    • Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque by Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
    • White H, Held C, Stewart R, Watson D, Harrington R, Budaj A, Steg PG, Cannon CP, Krug-Gourley S, Wittes J, Trivedi T, Tarka E,Wallentin L. Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease. Am Heart J 2010;160: 655-661.
    • (2010) Am Heart J , vol.160 , pp. 655-661
    • White, H.1    Held, C.2    Stewart, R.3    Watson, D.4    Harrington, R.5    Budaj, A.6    Steg, P.G.7    Cannon, C.P.8    Krug-Gourley, S.9    Wittes, J.10    Trivedi, T.11    Tarka, E.12    Wallentin, L.13
  • 20
    • 84905656517 scopus 로고    scopus 로고
    • Towards better clinical prediction models: Seven steps for development and an ABCD for validation
    • Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 2014;35: 1925-1931.
    • (2014) Eur Heart J , vol.35 , pp. 1925-1931
    • Steyerberg, E.W.1    Vergouwe, Y.2
  • 21
    • 84874529489 scopus 로고    scopus 로고
    • External validation of a Cox prognostic model: Principles and methods
    • Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol 2013;13:33.
    • (2013) BMC Med Res Methodol , vol.13 , pp. 33
    • Royston, P.1    Altman, D.G.2
  • 23
  • 24
    • 84861725443 scopus 로고    scopus 로고
    • Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study
    • Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500-1510.
    • (2012) Eur Heart J , vol.33 , pp. 1500-1510
    • Friberg, L.1    Rosenqvist, M.2    Lip, G.Y.3
  • 28
    • 84922480777 scopus 로고    scopus 로고
    • Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (Aristotle) trial
    • Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A, ARISTOTLE Investigators. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 2014;130:1847-1858.
    • (2014) Circulation , vol.130 , pp. 1847-1858
    • ARISTOTLE Investigators1    Wallentin, L.2    Hijazi, Z.3    Andersson, U.4    Alexander, J.H.5    De Caterina, R.6    Hanna, M.7    Horowitz, J.D.8    Hylek, E.M.9    Lopes, R.D.10    Asberg, S.11    Granger, C.B.12    Siegbahn, A.13
  • 29
    • 57149140461 scopus 로고    scopus 로고
    • Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
    • Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 2008;118:2029-2037.
    • (2008) Circulation , vol.118 , pp. 2029-2037
    • ACTIVE W Investigators1    Connolly, S.J.2    Pogue, J.3    Eikelboom, J.4    Flaker, G.5    Commerford, P.6    Franzosi, M.G.7    Healey, J.S.8    Yusuf, S.9
  • 30


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.